ME

23andMe (ME)

23andMe Holding Company

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ME

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	05 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/22	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/05/14	20 : 00	GlobeNewswire Inc.	Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals	NASDAQ:ME	23andMe Holding Company
2024/05/11	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/05/10	05 : 50	GlobeNewswire Inc.	23andMe to Report Q4 and Full Year FY2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/05/01	00 : 00	Business Wire	Potter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach Case	NASDAQ:ME	23andMe Holding Company
2024/04/25	05 : 05	GlobeNewswire Inc.	23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:ME	23andMe Holding Company
2024/04/18	21 : 00	GlobeNewswire Inc.	23andMe announces CEO’s intention to pursue a potential take-private	NASDAQ:ME	23andMe Holding Company
2024/04/06	05 : 05	GlobeNewswire Inc.	23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ME	23andMe Holding Company
2024/03/20	20 : 30	GlobeNewswire Inc.	23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6	NASDAQ:ME	23andMe Holding Company
2024/03/19	21 : 00	GlobeNewswire Inc.	23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago	NASDAQ:ME	23andMe Holding Company
2024/03/06	21 : 30	GlobeNewswire Inc.	23andMe Launches New Genetic Reports on Common Forms of Cancer	NASDAQ:ME	23andMe Holding Company
2024/03/06	06 : 30	GlobeNewswire Inc.	23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:ME	23andMe Holding Company
2024/02/22	06 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/02/08	06 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ME	23andMe Holding Company
2024/02/08	06 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/02/08	06 : 01	GlobeNewswire Inc.	23andMe Reports Third Quarter Fiscal 2024 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/02/06	21 : 00	Business Wire	Moneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc.	NASDAQ:ME	23andMe Holding Company
2024/01/31	21 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/01/31	12 : 12	GlobeNewswire Inc.	23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay	NASDAQ:ME	23andMe Holding Company
2024/01/31	07 : 00	Business Wire	Nighthawk Gold Obtains Final Court Order for the Proposed Arrangement	NASDAQ:ME	23andMe Holding Company
2024/01/25	06 : 05	GlobeNewswire Inc.	23andMe to Report FY2024 Third Quarter Financial Results	NASDAQ:ME	23andMe Holding Company
2024/01/22	22 : 00	Business Wire	Moneta Gold and Nighthawk Gold Announce the Proposed Directors for the MergeCo Board	NASDAQ:ME	23andMe Holding Company
2024/01/08	21 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2023/12/19	22 : 00	GlobeNewswire Inc.	23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts	NASDAQ:ME	23andMe Holding Company
2023/12/02	06 : 06	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ME	23andMe Holding Company
2023/11/28	21 : 15	Business Wire	Nighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development Company	NASDAQ:ME	23andMe Holding Company
2023/11/22	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2023/11/22	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2023/11/14	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company